(Sayre, PA) – Lung cancer is the leading cause of cancer deaths worldwide. More patients die every year from the disease than from prostate, breast and colon cancer combined.
Guthrie is proud to be the first health care system in our region to offer a Robotic Bronchoscope, the only device of its kind in the world, designed for patients with lung nodules. This new technology allows for earlier detection of lung cancer with greater accuracy.
Dr. Edmund Sabanegh, Guthrie President and CEO said, “Significant evolutions in the past decade have transformed surgery as we know it and Guthrie is committed to providing superior patient care and being a leader in health care excellence and innovation.”
After only having the robot in-house for about four months, more than 20 patients have been assessed using the Robotic Bronchoscope, more than 85 percent of those assessments resulting in a cancer diagnosis and subsequent treatment plan. An earlier diagnosis often means a better prognosis.